Emerald Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,162
Closed -$526K 262
2025
Q4
$526K Sell
3,162
-142
-4% -$23.8K 0.02% 166
2025
Q3
$647K Sell
3,304
-480
-13% -$78.9K 0.02% 173
2025
Q2
$342K Sell
3,784
-11,461
-75% -$906K 0.01% 197
2025
Q1
$910K Buy
15,245
+4,457
+41% +$412K 0.04% 133
2024
Q4
$1.43M Buy
10,788
+4,492
+71% +$422K 0.06% 126
2024
Q3
$330K Buy
6,296
+6,007
+2,079% +$282K 0.01% 199
2024
Q2
$17.5K Sell
289
-100
-26% -$6.94K ﹤0.01% 242
2024
Q1
$28.9K Buy
+389
New +$28.8K ﹤0.01% 234

Other funds holding ALAB

Emerald Advisers's ALAB Position: Q1 2026 in Review

Emerald Advisers sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 3,162 shares — an estimated $526K sold.

Emerald Advisers first reported a position in ALAB in Q1 2024 and held it in 8 quarters. The position peaked at $1.43M in Q4 2024. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Emerald Advisers reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Emerald Advisers sold 3,162 Astera Labs shares in Q1 2026, an estimated $526K.
  • Emerald Advisers first reported a position in Astera Labs in Q1 2024 and held it in 8 quarters.
  • Emerald Advisers's Astera Labs position peaked at $1.43M in Q4 2024.
  • 708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Emerald Advisers's 13F filing for Q1 2026, filed 4 May 2026.